Acute renal failure from contrast medium: Beware patients taking metformin…

BMJ

Volumn 333, Issue 7569, 2006, Pages 653-

  Sayer, John A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CONTRAST MEDIUM; METFORMIN; BIGUANIDE DERIVATIVE; IODINATED CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; RISK FACTOR; DEHYDRATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; HYPERCALCEMIA; INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION; LACTIC ACIDOSIS; LETTER; MULTIPLE MYELOMA; PATIENT MONITORING; PRIORITY JOURNAL;

CONTRAST MEDIA; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE, ACUTE; METFORMIN; RISK FACTORS;

EID: 33750127230     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.333.7569.653-a     Document Type: Letter

References (4)

1. Mathew R, Haque K, Woothipoom W. Acute renal failure induced by contrast medium: steps towards prevention. BMJ 2006: 333: 539–40.
2. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003: 76: 513–8.
3. Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994: 30: 187–228.
4. McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology 1992: 183: 519–21.